HYFT 1.64 ▼ -4.09% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    MindWalk Corp.

    NASDAQ: HYFT · Real-Time Price · USD
    1.64
    -0.07 (-4.09%)
    At close: Oct 16, 2025, 3:59 PM
    1.67
    1.83%
    After-hours: Oct 16, 2025, 07:03 PM EDT
    -4.09%
    Bid 1.6
    Market Cap 75.7M
    Revenue (ttm) 22.42M
    Net Income (ttm) -29.19M
    EPS (ttm) -0.6
    PE Ratio (ttm) -2.73
    Forward PE -8.57
    Analyst n/a
    Dividends n/a
    Ask 1.76
    Volume 601,709
    Avg. Volume (20D) 1,508,501
    Open 1.78
    Previous Close 1.71
    Day's Range 1.61 - 1.78
    52-Week Range 0.27 - 3.25
    Beta 0.69
    Ex-Dividend Date n/a

    About HYFT

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol HYFT
    Website n/a
    Full Company Profile

    Next Earnings Release

    MindWalk Corp. is scheduled to release its earnings on Dec 9, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 week ago
    +5.35%
    MindWalk Holdings shares are trading higher after ... Unlock content with Pro Subscription
    3 weeks ago
    +16.18%
    MindWalk shares are trading higher after the company announced an advancement of its AI-designed GLP-1 therapeutics program.
    news image

    1 day ago · businesswire.com

    MindWalk Appoints Dr. Thomas W. Lynch as Chief Business Officer to Accelerate Commercial Expansion

    AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #AI--MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), a Bio-Native AI company today announced the appointment of industry veteran...

    news image

    1 week ago · seekingalpha.com

    MindWalk Holdings Corp. (HYFT) ImmunoPrecise Antibodies Ltd. - Shareholder/Analyst Call Prepared Remarks Transcript

    MindWalk Holdings Corp. (NASDAQ:HYFT ) ImmunoPrecise Antibodies Ltd. - Shareholder/Analyst Call October 9, 2025 1:00 PM EDT Company Participants Jennifer Bath - CEO, President & Non-Independent Direct...

    news image

    1 week ago · businesswire.com

    MindWalk Announces Share Repurchase Program

    AUSTIN, Texas--(BUSINESS WIRE)---- $hyft #AI--MindWalk Holdings Corp. (“MindWalk” or the “Company”) (NASDAQ: “HYFT”), a bio-native AI company, today announced that to underscore its confidence in Mind...

    news image

    3 weeks ago · businesswire.com

    MindWalk Advances AI-Designed GLP-1 Program with First-in-Class Dual-Pathway Regimen for Aging and Longevity

    AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #AI--MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), a Bio-Native AI company, today announced a major advancement of its AI-desi...

    news image

    1 month ago · businesswire.com

    MindWalk Holdings Corp.™ (formerly ImmunoPrecise Antibodies™) Reports Record $7.6 Million Quarterly Revenue, 45% Growth, Margin Expansion, Narrowed Losses, and Strengthened Balance Sheet

    AUSTIN, Texas--(BUSINESS WIRE)---- $HYFT #AI--MindWalk Holdings Corp.™ (“MindWalk™”, “Company”, “we” or “us”) (NASDAQ: HYFT), a Bio-Native AI company operating at the intersection of TechBio and next-...

    news image

    1 month ago · businesswire.com

    ImmunoPrecise Rebrands as MindWalk, Announces NASDAQ Ticker Change to “HYFT”

    AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), ImmunoPrecise Antibodies Ltd. and its subsidiaries (BioStrand and Talem) today announ...

    news image

    2 months ago · businesswire.com

    ImmunoPrecise Antibodies Ltd. Divests Netherlands Facilities to AVS Bio to Accelerate Bio-Native AI Innovation

    AUSTIN, Texas--(BUSINESS WIRE)---- $IPA #AI--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a biotherapeutics company delivering advanced solutions in biologics and drug discove...

    news image

    2 months ago · businesswire.com

    AVS Bio, an Arlington Capital Partners Portfolio Company, Expands Antibody Discovery and Protein Production Capabilities With Acquisition of ImmunoPrecise Antibodies Europe From ImmunoPrecise Antibodies Ltd.

    WASHINGTON & NORWICH, Conn.--(BUSINESS WIRE)--Arlington Capital Partners (“Arlington”), a Washington, D.C.-area private investment firm specializing in government regulated industries, today announced...

    news image

    2 months ago · fool.com

    ImmunoPrecise (IPA) Q4 2025 Earnings Transcript

    Image source: The Motley Fool.

    news image

    2 months ago · seekingalpha.com

    ImmunoPrecise Antibodies Ltd. (IPA) Q4 2025 Earnings Conference Call Transcript

    ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA ) Q4 2025 Earnings Call July 29, 2025 10:30 AM ET Company Participants Jennifer Lynne Bath - CEO, President & Non-Independent Director Joseph Scheffler - Inte...

    Add to Watchlist